Promising new therapies for the treatment of hypercholesterolemia
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2016.1148136
Reference60 articles.
1. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2. Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
3. Statin-related adverse events: A meta-analysis
4. Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart Disease
5. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Artificial intelligence for dementia drug discovery and trials optimization;Alzheimer's & Dementia;2023-08-16
2. The Role of RNA Interference Therapeutics in Hypercholesterolemia and Implications for Practice;The Journal for Nurse Practitioners;2023-06
3. Atherosclerosis Potential Drug Targets: Current Scenario and Future Perspectives;Cardiovascular & Hematological Disorders-Drug Targets;2023-06
4. An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia;Expert Opinion on Pharmacotherapy;2020-02-08
5. Combined Lowering Effects of Rosuvastatin and L. acidophilus on Cholesterol Levels in Rat;Journal of Microbiology and Biotechnology;2019-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3